Thank you for finding more psudoscientific articles that are not published in scientific magazines where fellow scientists would have reviewed whether the paper was credible or not.
This article was first published in the Spring-Summer edition of The Scientific Review of Mental Health Practice.
* Adams, L., & Conn, S. (1997). Nutrition and its relationship to autism. Focus on Autism & Other Developmental Disabilities, 12, 53-58.
* Allen, J., DeMeyer, M. K., Norton, J. A., Pontus, W., & Yang, E. (1971). Intellectuality in parents of psychotic, subnormal, and normal children. Journal of Autism & Childhood Schizophrenia, 3, 311-326.
* Aman, M. G., & Langworthy, K. S. (2000). Pharmacotherapy for hyperactivity in children with autism and other pervasive developmental disorders. Journal of Autism and Developmental Disorders, 30, 451-459.
* American Academy of Child and Adolescent Psychiatry (1999). Practice parameters for the assessment and treatment of children, adolescents, and adults with autism and other pervasive developmental disorders. Journal of the American Academy of Child and Adolescent Psychiatry, 38, 32-54.
* American Academy of Pediatrics (1998). Auditory integration training and facilitated communication for autism. American Academy of Pediatrics. Committee on children with disabilities. Pediatrics, 102, 431-433.
* American Psychiatric Association (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: Author.
* Anderson, L. T., Campbell, M., Grega, D. M., Perry, R., Small, A. M., & Green, W. H. (1984). Haloperidol in the treatment of infantile autism: Effects on learning and behavioral symptoms. American Journal of Psychiatry, 141, 1195-1202.
* Anderson, S. R., Avery, D. L., DiPietro, E. K., Edwards, G. L., & Christian, W. P. (1987). Intensive home-based early intervention with autistic children. Education and Treatment of Children, 10, 352-366.
* Ayres, A. J. (1979). Sensory integration and the child. Los Angeles, CA: Western Psychological Services.
* Berand, G. (1993). Hearing equals behavior. New Canaan, CT: Keats.
* Beratis, S. (1994). A psychodynamic model for understanding pervasive developmental disorders. European Journal of Psychiatry, 8, 209-214.
* Bettelheim, B. (1967). The empty fortress. New York: Free Press.
* Bettison, S. (1996). The long-term effects of auditory training on children with autism. Journal of Autism & Developmental Disorders, 26, 361-374.
* Birnbrauer, J., & Leach, D. (1993). The Murdoch early intervention program after 2 years. Behavior Change, 10, 63-74.
* Bolman, W. M., & Richmond, J. A. (1999). A double-blind, placebo-controlled, crossover pilot trial of low dose dimethylglycine in patients with autistic disorder. Journal of Autism and Developmental Disorders, 29, 191-194.
* Brasic, J. R., Barnett, J. Y., Kaplan, D., Sheitman, B. B., Aisemberg, P., Lafargue, R. T., Kowalik, S., Clark, A., Tsaltas, M. O., & Young, J. G. (1994). Clomipramine ameliorates adventitious movements and compulsions in prepubertal boys with autistic disorder and severe mental retardation. Neurology, 44, 1309-1312.
* Brodkin, E. S., McDouble, C. J., Naylor, S. T., Cohen, D. J., & Price, L. H. (1997). Clomipramine in adults with pervasive developmental disorders: A prospective open-label investigation. Journal of Child and Adolescent Psychopharmacology, 7, 109-121.
* Bromfield, R. (2000). Its the tortoises race: Long-term psychodynamic psychotherapy with a high-functioning autistic adolescent. Psychoanalytic Inquiry, 20, 732-745.
* Bryson, S. (1997). Epidemiology of autism: Overview and issues outstanding. In D. J. Cohen & F. R. Volkmar (Eds.), Handbook of autism and pervasive developmental disorders (2nd ed., pp. 41-46). New York: Wiley.
* Bryson, S. E., Clark, B. S., & Smith, I. M. (1988). First report of a Canadian epidemiological study of autistic syndromes. Journal of Child Psychology and Psychiatry, 29, 433-445.
* Bunge, M. (1984). What is pseudoscience? Skeptical Inquirer, 9, 36-46.
* Burgess, C. A., Kirsch, I., Shane, H., Niederauer, K. L., Graham, S. M., & Bacon, A. (1998). Facilitated communication as an ideomotor response. Psychological Science, 9, 71-74.
* Campbell, M., Armenteros, J. L., Malone, R. P., Adams, P. B., Eisenberg, Z. W., & Overall, J. E. (1997). Neuroleptic-related dyskinesias in autistic children: A prospective, longitudinal study. Journal of the American Academy of Child and Adolescent Psychiatry, 36, 835-843.
* Campbell, M., Schopler, E., Cueva, J. E., & Hallin, A. (1996). Treatment of autistic disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 35, 134-143.
* Case-Smith, J., & Bryan, T. (1999). The effects of occupational therapy with sensory integration emphasis on preschool-age children with autism. American Journal of Occupational Therapy, 53, 489-497.
* Chez, M. G., & Buchanan, C. P. (2000). Reply to B. Rimlands "Comments on ‘Secretin and autism: A two-part clinical investigation. " Journal of Autism & Developmental Disorders, 30, 97-98.
* Chez, M. G., Buchanan, C. P., Bagan, B. T., Hammer, M. S., McCarthy, K. S., Ovrutskaya, I., Nowinski, C. V., & Cohen, Z. S. (2000). Secretin and autism: A two-part clinical investigation. Journal of Autism & Developmental Disorders, 30, 87-94.
* Cook, E. H., Rowlett, R., Jaselskis, C., & Leventhal, B. L. (1992). Fluoxetine treatment of children and adults with autistic disorder and mental retardation. Journal of the American Academy of Child and Adolescent Psychiatry, 31, 739-745.
* Cooper, J. O., Heron, T., & Heward, W. (1989). Applied behavior analysis. Columbus, OH: Merrill.
* Dales, L., Hammer, S. J., & Smith, N. J. (2001). Time trends in autism and in MMR immunization coverage in California. Journal of the American Medical Association, 285, 1183-1185.
* Darnton, N. (1990, September 10). Beno Brutalheim? Newsweek, 111(11), 59-60.
* Dawson, G., & Osterling, J. (1997). Early intervention in autism: Effectiveness and common elements of current approaches. In M. Guralnick (Ed.), The effectiveness of early intervention (pp. 307-326). Baltimore: Brookes.
* Dawson, G., & Watling, R. (2000). Interventions to facilitate auditory, visual, and motor integration in autism: A review of the evidence. Journal of Autism & Developmental Disorders, 30, 415-421.
* DeLong, G. R., Teague, L. A., & Kamran, M. M. (1998). Effects of fluoxetine treatment in young children with idiopathic autism. Developmental Medicine and Child Neurology, 40, 551-562.
* Denson, J. F., Nuthall, G. A., Bushnell, J., & Horn, J. (1989). Effectiveness of a sensory integrative therapy program for children with perceptual-motor deficits. Journal of Learning Disabilities, 22, 221-229.
* Deutsch, R. M., & Morrill, J. S. (1993). Realities of nutrition. Palo Alto, CA: Bull Publishing.
* Dunn-Geier, J., Ho H. H., Auersperg, E., Doyle, D., Eaves, L., Matsuba, C., Orrbine, E., Pham, B., & Whiting, S. (2000). Effect of secretin on children with autism: A randomized controlled trial. Developmental Medicine & Child Neurology, 42, 796-802.
* Edelson, S. M. (2001). Disappointed [Letter to the editor]. Priorities for Health, 13(1), 4-6.
* Edelson, S. M., Arin, D., Bauman, M., Lukas, S. E., Rudy, J. H., Sholar, M., Rimland, B. (1999). Auditory integration training: A double-blind study of behavioral and electrophysiological effects in people with autism. Focus on Autism and Other Developmental Disabilities, 14, 73-81.
* Fatemi, S. H., Realmuto, G. M., Khan, L., & Thuras, P. (1998). Fluoxetine in treatment of adolescent patients with autism: A longitudinal open trial. Journal of Autism & Developmental Disorders, 28, 303-307.
* Fenske, E. C., Zalenski, S., Krantz, P. J., & McClannahan, L. E. (1985). Age at intervention and treatment outcome for autistic children in a comprehensive intervention program. Analysis and Intervention in Developmental Disabilities, 5, 49-58.
* Findling, R. L., Maxwell, K., Scotese-Wojtila, L., & Huang, J. (1997). High-dose pyridoxine and magnesium administration in children with autistic disorder: An absence of salutary effects in a double-blind, placebo-controlled study. Journal of Autism & Developmental Disorders, 27, 467-478.
* Folstein, S. E. (1999). Autism. International Review of Psychiatry, 11, 269-278.
* Fombonne, E. (1998). Epidemiology of autism and related conditions. In F. R. Volkmar (Ed.), Autism and pervasive developmental disorders (pp. 32-63). New York: Cambridge University Press.
* Gardner, M. (2000). The brutality of Dr. Bettelheim. Skeptical Inquirer, 24(6), 12-14.
* Gardner, M. (2001). Facilitated communication: A cruel farce. Skeptical Inquirer, 25, 17-19.
* Gillberg, C. (1996). The psychopharmacology of autism and related disorders. Journal of Psychopharmacology, 10, 54-63.
* Gillberg, C., Johansson, M., Steffenburg, S., & Berlin, O. (1997). Auditory integration training in children with autism: Brief report of an open pilot study. Autism, 1, 97-100.
* Gordon, C. T., Rapoport, J. L., Hamburger, S. D., State, R. C., & Mannheim, G. B. (1992). Differential response of seven subjects with autistic disorder to clomipramine and desipramine. American Journal of Psychiatry, 149, 363-366.
* Gordon, C. T., State, R. C., Nelson, J. E., Hamburger, S. D., & Rapoport, J. L. (1993). A double-blind comparison of clomipramine, desipramine, and placebo in the treatment of autistic disorder. Archives of General Psychiatry, 50, 441-447.
* Gorman, B. J. (1999). Facilitated communication: Rejected in science, accepted in courtta case study and analysis of the use of FC evidence under Frye and Daubert. Behavioral Sciences and the Law, 17, 517-541.
* Green, D. (2001). Autism and "voodoo science" treatments. Priorities for Health, 13(1), 27-32, 69.
* Green, G. (1994). Facilitated communication: Mental miracle or sleight of hand? Skeptic, 2, 68-76.
* Green, G. (1996a). Evaluating claims about treatments for autism. In C. Maurice, G. Green, & S. C. Luce (Eds.), Behavioral intervention for young children with autism: A manual for parents and professionals (pp. 15-28). Austin, TX: PRO-ED.
* Green, G. (1996b). Early behavioral intervention for autism: What does research tell us? In C. Maurice, G. Green, & S. C. Luce (Eds.), Behavioral intervention for young children with autism: A manual for parents and professionals (pp. 29-44). Austin, TX: PRO-ED.
* Gresham, F. M., Beebe-Frankenberger, M. E., & MacMillan, D. L. (1999). A selective review of treatments for children with autism: Description and methodological considerations. School Psychology Review, 28, 559-576.
* Gresham, F. M., & MacMillan, D. L. (1998). Early intervention project: Can its claims be substantiated and its effects replicated? Journal of Autism & Developmental Disorders, 28, 5-13.
* Harris, S. L., Handleman, J. S., Gordon, R., Kristoff, B., & Fuentes, F. (1991). Changes in cognitive and language functioning of preschool children with autism. Journal of Autism and Developmental Disorders, 21, 281-290.
* Herbert, J. D. Lilienfeld, S. O., Lohr, J. M., Montgomery, R. W., ODonohue, W. T., Rosen, R. M., & Tolin, D. F. (2000). Science and pseudoscience in the development of eye movement desensitization and reprocessing: Implications for clinical psychology. Clinical Psychology Review, 20, 945-971.
* Herbert, J. D., & Sharp, I. R. (2001). Pseudoscientific treatments for autism. Priorities for Health, 13(1), 23-26, 59.
* Hoehn, T. P., & Baumesiter, A. A. (1994). A critique of the application of sensory integration therapy to children with learning disabilities. Journal of Learning Disabilities, 27, 338-351.
* Horvath, K., Stefanatos, G., Sokolski, K. N., Wachtel, R., Nabors, L., & Tildon, J. T. (1998). Improved social and language skills after secretin administration in patients with autistic spectrum disorders. Journal of the Association for Academic Minority Physicians, 9, 9-15.
* Hoyson, M., Jamieson, B., & Strain, P. S. (1984). Individualized group instruction of normally developing and autistic-like children: The LEAP curriculum model. Journal of the Division of Early Childhood, 8, 157-172.
* Iwasaki, K., & Holm, M. B. (1989). Sensory treatment for the reduction of stereotypic behaviors in persons with severe multiple disabilities. Occupational Therapy Journal of Research, 9, 170-183.
* Jacobson, J. W., Mulick, J. A., & Green, G. (1998). Cost-benefit estimates for early intensive behavioral intervention for young children with autismtGeneral model and single state case. Behavioral Interventions, 13, 201-226.
* Jacobson, J. W., Mulick, J. A., & Schwartz, A. A. (1995). A history of facilitated communication: Science, pseudoscience, and antiscience: Science working group on facilitated communication. American Psychologist, 50, 750-765.
* Jenkins, J. R., Fewell, R. R., & Harris, S. R. (1984). Comparison of sensory integrative therapy and motor programming. American Journal of Mental Deficiency, 88, 221-224.
* Kanner, L. (1946). Autistic disturbances of affective contact. American Journal of Psychiatry, 103, 242-246.
* Kanner, L. (1973). Childhood psychosis: Initial studies and new insights. Washington, DC: V. H. Winston & Sons.
* Kaufman, B. N. (1976). Son rise. New York: Harper & Row.
* Kaye, J. A., Melero-Montes, M., & Jick, H. (2001). Mumps, measles, and rubella vaccine and the incidence of autism recorded by general practitioners: A time trend analysis. British Medical Journal, 322, 460-463.
* King, B. H. (2000). Pharmacological treatment of mood disturbances, aggression, and self-injury in persons with pervasive developmental disorders. Journal of Autism & Developmental Disorders, 30, 439-445.
* Kirsch, I., & Lynn, S. J. (1999). Automaticity in clinical psychology. American Psychologist, 54, 504-515.
* Kvinsberg, A. M., Reichelt, K. L., Nodland, M., Hoien, T. (1996). Autistic syndromes and diet: A follow-up study. Scandinavian Journal of Educational Research, 39, 223-236.
* Lilienfeld, S. O. (1998). Pseudoscience in contemporary clinical psychology: What it is and what we can do about it. The Clinical Psychologist, 51, 3-9.
* Linderman, T. M., & Stewart, K. B. (1999). Sensory integrative-based occupational therapy and functional outcomes in young children with pervasive developmental disorders: A single-subject study. American Journal of Occupational Therapy, 53, 207-213.
* Locascio, J. J., Malone, R. P., Small, A. M., Kafantaris, V., Ernst, M., Lynch, N. S., Overall, J. E., & Campbell, M. (1991). Factors related to haloperidol response and dyskinesias in autistic children. Psychopharmacology Bulletin, 27, 119-126.
* Lovaas, O. I. (1981). Teaching developmentally disabled children: The me book. Austin, TX: PRO-ED.
* Lovaas, O. I. (1987). Behavioral treatment and normal educational and intellectual functioning in young autistic children. Journal of Consulting and Clinical Psychology, 55, 3-9.
* Mahler, M. (1968). On human symbiosis and the vicissitudes of individuation. New York: International Universities Press.
* Manning, A. (1999, August 16). Vaccine-autism link feared. USA Today.
* Marrosu, F., Marrosu, G., Rachel, M. G., & Biggio, G. (1987). Paradoxical reactions elicited by diazepam in children with classic autism. Functional Neurology, 3, 355-361.
* Mason, S. M., & Iwata, B. A. (1991). Artifactual effects of sensory-integrative therapy on self-injurious behavior. Journal of Applied Behavior Analysis, 23, 361-370.
* McCormick, L. H. (1997). Treatment with buspirone in a patient with autism. Archives of Family Medicine, 6, 368-370.
* McDougle, C. J., Holmes, J. P., Carlson, D. C., Pelton, G., Cohen, D. J., & Price, L. H. (1998). A double-blind, placebo-controlled study of risperidone in adults with autistic disorder and other pervasive developmental disorders. Archives of General Psychiatry, 55, 633-641.
* McDougle, C. J., Kresch, L. E., & Posey, D. J. (2000). Repetitive thoughts and behavior in pervasive developmental disorders: Treatment with serotonin reuptake inhibitors. Journal of Autism & Developmental Disorders, 30, 427-435.
* McDougle, C. J., Naylor, S. T., Cohen, D. J., Volkmar, F. R., Heninger, G. R., & Price, L. H. (1996). A double-blind, placebo-controlled study of fluvoxamine in adults with autistic disorder. Archives of General Psychiatry, 53, 1001-1008.
* McEachlin, J., Smith, T., & Lovaas, O. I. (1993). Long-term outcome for children with autism who received early intensive behavioral treatment. American Journal on Mental Retardation, 97, 359-372.
* Mesibov, G. B. (1993). Treatment outcome is encouraging. American Journal on Mental Retardation, 97, 379-380.
* Mudford, O. C. (1995). Review of the gentle teaching data. American Journal on Mental Retardation, 99, 345-355.
* Mudford, O. C., Cross, B. A., Breen, S., Cullen, C., Reeves, D., Gould, J., Douglas, J. (2000). Auditory integration training for children with autism: No behavioral benefits detected. American Journal on Mental Retardation, 105, 118-129.
* Mundy, P. (1993). Normal versus high-functioning status in children with autism. American Journal on Mental Retardation, 97, 381-384.
* New update. (1999, August). Psychopharmacology Update, 10, 2.
* Owley, T., Steele, E., Corsello, C., Risi, S., McKaig, K., Lord, C., Leventhal, B. L., & Cook, E. H. (1999). A double-blind placebo-controlled trial of secretin for the treatment of autistic disorder. Medscape General Medicine, 1. Retrieved December 6, 2001, from
http://www.medscape. com/medscape/GeneralMedicine/journal/1999/v01.n10/ mgm1006.owle/mgm1006.owle-01.html.
* Ozonoff, S., & Cathcart, K. (1998). Effectiveness of a home program intervention for young children with autism. Journal of Autism & Developmental Disorders, 28, 25-32.
* Pollak, R. (1997). Creation of Dr. Bettelheim: A biography of Bruno Bettelheim. New York: Simon & Schuster.
* Ratey, J. J., Mikkelsen, E., Chmielinski, H. E. (1989). Buspirone therapy for maladaptive behaviors and anxiety in developmentally disabled persons. Journal of Clinical Psychiatry, 50, 382-384.
* Realmuto, G. M., August, G. J., & Garfinkel, B. D. (1989). Clinical effect of buspirone in autistic children. Journal of Clinical Psychopharmacology, 9, 122-125.
* Reilly, C., Nelson, D. L., & Bundy, A. C. (1984). Sensorimotor versus fine motor activities in eliciting vocalizations in autistic children. Occupational Therapy Journal of Research, 3, 199-212.
* Rimland, B. (1988). Candida-caused autism? Autism Research Review International Newsletter. Retrieved December 6, 2001, from
http://www.autism.com/ari/editorials/candida. html.
* Rimland, B. (1996). Dimethylglycine (DMG), a nontoxic metabolite, and autism. Autism Research Review International. Retrieved December 6, 2001, from
http://www. autism.com/ari/editorials/dmg1.html.
* Rimland, B. (1999). The use of secretin in autism: Some preliminary answers. Autism Research Review International Newsletter. Retrieved December 6, 2001, from http://
www.autism.com/ari/editorials/findings.html.
* Rimland, B. (2000, April 26). Do childrens shots invite autism? Los Angeles Times. Retrieved from
http://www. latimes.com/archives.
* Rimland, B., & Edelson, S. M. (1994). The effects of auditory integration training on autism. American Journal of Speech-Language Pathology, 5, 16-24.
* Rimland, B., & Edelson, S. M. (1995). Auditory integration training in autism: A pilot study. Journal of Autism & Developmental Disorders, 25, 61-70.
* Rodier, P. M. (2000). The early origins of autism. Scientific American, 282, 56-63.
* Rogers, S. J. (1998). Empirically supported comprehensive treatments for young children with autism. Journal of Clinical Child Psychology, 27, 168-179.
* Rogers, S. J., & DiLalla, D. (1991). A comparative study of a developmentally based preschool curriculum on young children with autism and young children with other disorders of behavior and development. Topics in Early Childhood Special Education, 11, 29-48.
* Rogers, S. J., Herbison, J., Lewis, H., Pantone, J., & Reis, K. (1986). An approach for enhancing the symbolic, communicative, and interpersonal functioning of young children with autism and severe emotional handicaps. Journal of the Division of Early Childhood, 10, 135-148.
* Rogers, S. J., & Lewis, H. (1989). An effective day treatment model for young children with pervasive developmental disorders. Journal of the American Academy of Child and Adolescent Psychiatry, 28, 207-214.
* Rogers, S. J., Lewis, H. C., & Reis, K. (1987). An effective procedure for training early special education teams to implement a model program. Journal of the Division of Early Childhood, 11, 180-188.
* Roser, K. (1996). A review of psychoanalytic theory and treatment of childhood autism. Psychoanalytic Review, 83, 325-341.
* Sanchez, L. E., Campbell, M., Small, A. M., Cueva, J. E., Armenteros, J. L., & Adams, P. B. (1996). A pilot study of clomipramine in young autistic children. Journal of the American Academy of Child and Adolescent Psychiatry, 35, 537-544.
* Sandler, A. D., Sutton, K. A., DeWeese, J., Girardi, M. A., Sheppard, V., & Bodfish, J. W. (1999). Lack of benefit of a single dose of synthetic human secretin in the treatment of autism and pervasive developmental disorder. New England Journal of Medicine, 341, 1801-1806.
* Schopler, E., Mesibov, G. B., & Baker, A. (1982). Evaluation of treatment for autistic children and their parents. Journal of the American Academy of Child Psychiatry, 21, 262-267.
* Schopler, E., & Reichler, R. J. (1971). Parents as cotherapists in the treatment of psychotic children. Journal of Autism and Childhood Schizophrenia, 1, 87-102.
* Schopler, E., Reichler, R. J., Bashford, A., Lansing, M. D., Marcus, L. M. (1990). Individualized assessment and treatment for autistic and developmentally disables children (Vol. 1): Psychoeducational profile revised. Austin, TX: PRO-ED.
* Schopler, E., Short, A., & Mesibov, G. (1989). Relation of behavioral treatment to "normal functioning": Comments on Lovaas. Journal of Consulting and Clinical Psychology, 57, 162-164.
* Sheinkopf, S., & Siegel, B. (1998). Home-based behavioral treatment of young children with autism. Journal of Autism & Developmental Disorders, 28, 15-23.
* Siegel, B. (1996). The world of the autistic child: Understanding and treating autistic spectrum disorders. New York: Oxford University Press.
* Schreibman, L. (2000). Intensive behavioral/psychoeducational treatments for autism: Research needs and future directions. Journal of Autism & Developmental Disorders, 30, 373-378.
* Shermer, M. (1997). Why people believe weird things: Pseudoscience, superstition, and other confusions of our time. New York: W. H. Freeman.
* Smith, T. (1996). Are other treatments effective? In C. Maurice, G. Green, & S. C. Luce (Eds.), Behavioral intervention for young children with autism: A manual for parents and professionals (pp. 45-59). Austin, TX: PRO-ED.
* Steffenburg, S., & Gillberg, C. (1986). Autism and autistic-like conditions in Swedish rural and urban areas: A population study. British Journal of Psychiatry, 149, 81-87.
* Stehli, A. (1991). The sound of a miracle: A childs triumph over autism. New York: Doubleday.
* Stratton, K., Gable, A., Shetty, P., & McCormick, M. (Eds.) (2001). Immunization safety review: Measles-mumps-rubella vaccine and autism. Washington, DC: National Academy Press.
* Stromland, K., Nordin, V., Miller, M., Akerstrom, B., & Gillberg, C. (1994). Autism in thalidomide embryopathy: A population study. Developmental Medicine and Child Neurology, 36, 351-356.
* Sugiyama, T., & Abe, T. (1989). The prevalence of autism in Nagoya, Japan: A total population study. Journal of Autism & Developmental Disorders, 19, 87-96.
* Tolbert, L. C., Haigler, T., Waits, M. M., & Dennis, T. (1993). Brief report: Lack of response in an autistic population to a low dose clinical trial of pyridoxine plus magnesium. Journal of Autism & Developmental Disorders, 23, 193-199.
* Trottier, G., Srivastava, L., & Walker, C. D. (1999). Etiology of infantile autism: A review of recent advancements in genetic and neurobiological research. Journal of Psychiatry & Neuroscience, 24, 103-115.
* Tustin, F. (1981). Autistic states in children. Boston: Routledge.
* Volkmar, F. R., Szatmari, P., & Sparrow, S. S. (1993). Sex differences in pervasive developmental disorders. Journal of Autism & Developmental Disorders, 23, 579-591.
* Wakefield, A. J., Murch, S. H., Anthony, A., Linnell, J., Casson, D. M., Malik, M., Berelowitz, M., Dhillon, A. P., Thomson, M. A., Harvey, P., Valentine, A., Davies, S. E., & Walker-Smith, J. A. (1998). Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet, 351, 637-641.
* Welch, M. G. (1988). Holding time: How to eliminate conflict, temper tantrums, and sibling rivalry and raise happy, loving, successful children. New York: Simon & Schuster.
* Wheeler, D. L., Jacobson, J. W., Paglieri, R. A., & Schwartz, A. A. (1993). An experimental assessment of facilitated communication. Mental Retardation, 31, 49-59.
* Whiteley, P., Rodgers, J., Savery, D., & Shattock, P. (1999). A gluten-free diet as an intervention for autism and associated spectrum disorders: Preliminary findings. Autism, 3, 45-65.
* Zollweg, W., Palm, D., & Vance, V. (1997). The efficacy of auditory integration training: A double blind study. American Journal of Audiology, 6, 39-47.
But of course they expose all the lies and false claims made by the aba crowd, so you sadly hide your head in the sand and dismiss it.
You seem to continously misrepresent facts to support your claims. In the UCLA study 46% percent improved so much that they were enrolled i normal 1 grade classes WITHOUT additional support and without thachers being able to point out the treated children, and except for one student that continued to regress, the reminder were placed in settings with various levels of support. A fantastic succes!
Try a fantastic falsehood! None of those kids were followed into adult hood and the study is now being dismissed as terribly flawed and based on fase data the least of which is the garbage about raising IQ's.
Not I. The evidence is clear. aba is rife with false claims and doubtful conclusions. TEACCH makes true claims and is supported by research such as I quoted in the